These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8208766)

  • 1. Assessing spiradoline-like discriminative effects of DuP 747: influence of route of administration.
    Holtzman SG; Steinfels GF; Schmidt WK
    Pharmacol Biochem Behav; 1994 Mar; 47(3):487-91. PubMed ID: 8208766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of the discriminative stimulus effects of spiradoline.
    Holtzman SG
    Pharmacol Biochem Behav; 2000 Jul; 66(3):517-22. PubMed ID: 10899364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of the discriminative stimulus effects of the kappa-opioid agonist spiradoline.
    Holtzman SG; Steinfels GF
    Psychopharmacology (Berl); 1994 Nov; 116(3):243-8. PubMed ID: 7892412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of spiradoline, a kappa-opioid agonist.
    Holtzman SG; Cook L; Steinfels GF
    Psychopharmacology (Berl); 1991; 105(4):447-52. PubMed ID: 1663252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of dextromethorphan in the rat.
    Holtzman SG
    Psychopharmacology (Berl); 1994 Nov; 116(3):249-54. PubMed ID: 7892413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine systems in the discriminative effects of spiradoline, a kappa-opioid agonist.
    Holtzman SG; Steinfels GF
    Pharmacol Biochem Behav; 1994 Mar; 47(3):575-8. PubMed ID: 8208776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the discriminative and neuroendocrine effects of centrally penetrating kappa-opioid agonists in rhesus monkeys.
    Butelman ER; Ball JW; Kreek MJ
    Psychopharmacology (Berl); 2002 Oct; 164(1):115-20. PubMed ID: 12373425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
    Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
    Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral Characterization of κ Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats.
    Minervini V; Dahal S; France CP
    J Pharmacol Exp Ther; 2017 Feb; 360(2):280-287. PubMed ID: 27903642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of mesolimbic kappa-opioid systems in the discriminative stimulus effects of morphine.
    Spanagel R; Shoaib M
    Neuroscience; 1994 Dec; 63(3):797-804. PubMed ID: 7898679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist.
    Wadenberg ML
    CNS Drug Rev; 2003; 9(2):187-98. PubMed ID: 12847558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus properties and brain distribution of phencyclidine in rats following administration by injection and smoke inhalation.
    Wessinger WD; Martin BR; Balster RL
    Pharmacol Biochem Behav; 1985 Oct; 23(4):607-12. PubMed ID: 2999833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine.
    Walker EA; Young AM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):322-30. PubMed ID: 8229759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus properties of 7-OH-DPAT, a dopamine D3-selective receptor ligand.
    McElroy JF
    Pharmacol Biochem Behav; 1994 Jun; 48(2):531-3. PubMed ID: 7916465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal absorption of a kappa agonist analgesic.
    Hussain MA; Schmidt WK; Buehler JD
    Pharm Res; 1993 Jul; 10(7):1083-6. PubMed ID: 8397395
    [No Abstract]   [Full Text] [Related]  

  • 16. Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid.
    Vonvoigtlander PF; Lewis RA
    J Pharmacol Exp Ther; 1988 Jul; 246(1):259-62. PubMed ID: 2839665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats.
    Smith MA; French AM
    Psychopharmacology (Berl); 2002 Jul; 162(3):255-64. PubMed ID: 12122483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic studies on DOM as a discriminative stimulus.
    Glennon RA; Hauck AE
    Pharmacol Biochem Behav; 1985 Dec; 23(6):937-41. PubMed ID: 2934750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of the kappa agonist-spiradoline (U62066E) on the analgesic activity of some opioids at the spinal level.
    Stachura Z; Herman ZS
    Pol J Pharmacol; 1994; 46(1-2):37-41. PubMed ID: 7981769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of the discriminative stimulus effects of (+)-7-OH-DPAT by remoxipride but not PNU-99194A.
    Christian AJ; Goodwin AK; Baker LE
    Pharmacol Biochem Behav; 2001 Mar; 68(3):371-7. PubMed ID: 11325388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.